article thumbnail

6 challenges healthtech can help us tackle – Pt.2

Digital Health Global

Drug development The traditional drug discovery process is characterized by its protracted timeline, high costs, and significant attrition rates among drug candidates. There are three main advantages to the use of AI in drug development: width of research, speed of execution, low costs. 2021 [6] Regina M.

article thumbnail

Where are HealthTech's soft landing M&A deals in today's market?

Lloyd Price

Companies with niche technologies or expertise: Startups with unique solutions in specific areas like AI-powered diagnostics, remote patient monitoring, or telehealth platforms. Pharmaceutical and Life Sciences Companies: These companies are looking for HealthTech solutions to: Enhance clinical trials and drug development processes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

But returning to Erin Moore’s point, how do we get researchers, clinicians, and industry engaged to listen to patients in clinical trial design, pharma/biotech drug development and health tech capability? She was the patient keynote speaker at DPHARM 2021 and is a HIMSS Digital Health Influencer. Connect with her at [link].

BioTech 107
article thumbnail

Key trends expected to shape Pain Management and Adherence markets in 2024 and beyond

Lloyd Price

Telehealth: Remote consultations and monitoring for improved accessibility and convenience. Preventative care: Utilizing wearables and biosensors for early pain detection and intervention to prevent chronic pain development. In 2021, only 1.3% billion for oncology.

article thumbnail

Teladoc Livongo merger: what went wrong with the 'one-stop shop for virtual care' strategy?

Lloyd Price

2021: The integration of the two companies is underway. Primary services include telehealth, medical opinions, AI and analytics, telehealth devices and licensable platform services. The company's first product was a telehealth platform that allowed patients to connect with doctors via videoconferencing.